Regeneron Pharmaceuticals, Inc.
Methods for Enhancing Efficacy of a Vaccine by Administering an IL-4R Antagonist
Last updated:
Abstract:
The present invention provides methods for enhancing the efficacy and/or safety of a vaccine. In certain embodiments, the invention provides methods to increase or potentiate the immune response to a vaccine in a subject in need thereof. The methods of the present invention comprise administering to a subject in need thereof an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody in combination with said vaccine. In certain embodiments, the methods of the present invention are used to afford enhanced protection to an infectious disease such as whooping cough.
Status:
Application
Type:
Utility
Filling date:
29 Apr 2019
Issue date:
24 Oct 2019